Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271

Diabetes Care. 2024 Aug 1;47(8):e63-e64. doi: 10.2337/dci24-0031.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose Self-Monitoring
  • Blood Glucose* / analysis
  • Blood Glucose* / metabolism
  • Continuous Glucose Monitoring
  • Fructosamine* / blood
  • Glycated Hemoglobin* / metabolism
  • Glycated Serum Albumin*
  • Glycation End Products, Advanced*
  • Glycemic Control
  • Humans
  • Kidney Failure, Chronic* / blood
  • Kidney Failure, Chronic* / therapy
  • Serum Albumin* / metabolism

Substances

  • Glycated Hemoglobin
  • Glycated Serum Albumin
  • Glycation End Products, Advanced
  • Blood Glucose
  • Fructosamine
  • Serum Albumin